baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Tonix Pharmaceuticals Holding Cor.../ US8902608541 /

2024-04-17 10:00:00 PM	Chg. +0.0095	Volume	Bid1:57:46 PM	Ask1:57:46 PM	High	Low
0.1594USD	+6.34%	2.03 mill. Turnover: 276,975.0230	0.1593Bid Size: 100	0.1594Ask Size: 46,000	0.1600	0.1450

GlobeNewswire 04-01 Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Hi...

GlobeNewswire 03-28 Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct Offering

GlobeNewswire 03-25 Tonix Pharmaceuticals Receives Rare Pediatric Disease Designation from the FDA for TNX-2900 for the ...

GlobeNewswire 03-21 Tonix Pharmaceuticals Announces Poster Presentation Describing Discovery of Novel Next-Generation Ox...

GlobeNewswire 03-20 Tonix Pharmaceuticals Announces Selection of Two Contract Manufacturing Organizations for the Launch...

GlobeNewswire 03-19 Tonix Pharmaceuticals Announces Transition to Fully Integrated Biopharmaceutical Company Expected on...

GlobeNewswire 03-12 Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring

GlobeNewswire 03-11 Tonix Pharmaceuticals Reports Improvement in “Brain Fog,” in Fibromyalgia Patients Treated with Tonm...

GlobeNewswire 03-07 Tonix Pharmaceuticals Announces Publication in Psychiatry Research Showing Activity of Bedtime TNX-1...

GlobeNewswire 03-06 Tonix Pharmaceuticals Selects EVERSANA® to Support Launch Strategy and Commercialization Planning of...

GlobeNewswire 03-05 Tonix Pharmaceuticals Announces Translation of Preclinical Pharmacokinetic Parameters of TNX-1500 (F...

GlobeNewswire 02-29 Tonix Pharmaceuticals Announces Presentation at The 6th International Congress on Controversies in F...

GlobeNewswire 02-28 Tonix Pharmaceuticals Completes Clinical Stage of Phase 1 Trial for TNX-1500 (Fc-modified humanized ...

GlobeNewswire 02-27 Tonix Pharmaceuticals Announces Positive Results from Clinical Pharmacokinetic Bridging Study of Ton...

GlobeNewswire 02-20 Tonix Pharmaceuticals to Participate in the 2024 BIO CEO & Investor Conference

GlobeNewswire 02-15 Global Fibromyalgia Treatment Market Expected to Reach $4.6 billion by 2032

GlobeNewswire 02-14 Tonix Pharmaceuticals Hosted KOL Webinar on Positive Phase 3 Fibromyalgia Trial for Tonmya™, Plans t...

GlobeNewswire 02-13 Tonix Pharmaceuticals Announces Engagement of Rho as CRO to Support Submission of New Drug Applicati...

GlobeNewswire 02-12 Tonix Pharmaceuticals Announces FDA IND Clearance for DoD Funded Trial of TNX-102 SL for the Reducti...

GlobeNewswire 01-29 Tonix Pharmaceuticals Announces Conditional Acceptance of Tonmya™ as Trade Name for TNX-102 SL for t...

GlobeNewswire 01-25 Tonix Pharmaceuticals Announces KOL Webinar to Discuss Positive Phase 3 Fibromyalgia Data, Sponsored...

GlobeNewswire 01-09 Tonix Pharmaceuticals Presents Additional Data Highlighting the Favorable Tolerability and Different...

GlobeNewswire 01-03 Tonix Pharmaceuticals to Present at Two Upcoming Investor Conferences in January: Focus is on TNX-10...

GlobeNewswire 2023-12-20 Tonix Pharmaceuticals Announces Registered Direct Offering of up to $144 Million

GlobeNewswire 2023-12-20 Tonix Pharmaceuticals Announces Highly Statistically Significant and Clinically Meaningful Topline R...

Tonix Pharmaceuticals Holding Cor.../ US8902608541 /

If you wish to receive reply to your feedback, please provide your email address.